| 摘要 |
The invention provides a pharmaceutical formulation comprising voriconazole, or a pharmaceutically acceptable derivative thereof, and a cyclodextrin derivative of formula (I), wherein R1a-g, R2a-g and R3a-g independently represent OH or O(CH2)4SO3H; or a pharmaceutically acceptable salt thereof. |
